The dysregulation of calcium signaling, as evidenced by the elevated intracellular calcium levels and the reduced expression of STIM1 and ORAI1, suggests a complex interplay in the pathophysiology of MS. This evidence concerns the gene STIM1 and myeloid sarcoma.